1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bulgaria Pharmaceuticals and Healthcare Report Q4 2016

Bulgaria Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 80 pages

Includes 3 FREE quarterly updates


BMI View:

Bulgaria's expanding private healthcare market will provide significant revenue-earning opportunities for multinational pharmaceutical firms and medical device manufacturers. The poor state of the public healthcare system and the liberalisation of the private sector will see a rapid increase in private healthcare usage as the demand for more advanced and high-quality treatment rises. This trend is likely to be echoed across the Balkan region. Headline Expenditure Projections

- Pharmaceuticals: BGN2.71bn (USD1.54bn) in 2015 to BGN2.89bn (USD1.58bn) in 2016; +6.6% in local currency terms and +2.5% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: BGN7.45bn (USD4.22bn) in 2015 to BGN7.85bn (USD4.28bn) in 2016; +5.4% in local currency terms and +1.5% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Bulgaria Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Bulgaria 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2014-2020) 28
Industry Risk/Reward Index 29
Central And Eastern Europe Risk/Reward Index - Q4 2016 29
Bulgaria Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 38
Intellectual Property Issues 40
Pricing Regime 41
Reimbursement Regime 44
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Bulgaria 2010-2015) 49
Table: Healthcare Resources (Bulgaria 2010-2015) 49
Table: Healthcare Personnel (Bulgaria 2010-2015) 50
Table: Healthcare Activity (Bulgaria 2010-2015) 50
Table: NHIF Budget, 2014 54
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015 54
Research and Development 55
Table: Members Of ARPharM, 2014 55
Clinical Trials 56
Table: Cancer Incidence Rates, 2012-2035 59
Competitive Landscape 60
Research-Based Industry 60
Table: Multinational Market Activity 61
Generic Drugmakers 62
Pharmaceutical Retail Sector 62
Table: Pharmaceutical Wholesale And Retail Market, 2009-2012 64
Company Profile 65
Sopharma 65
Demographic Forecast 69
Demographic Outlook 69
Table: Population Headline Indicators (Bulgaria 1990-2025) 70
Table: Key Population Ratios (Bulgaria 1990-2025) 70
Table: Urban/Rural Population and Life Expectancy (Bulgaria 1990-2025) 71
Table: Population By Age Group (Bulgaria 1990-2025) 71
Table: Population By Age Group % (Bulgaria 1990-2025) 72
Glossary 74
Methodology 76
Pharmaceutical Expenditure Forecast Model 76
Healthcare Expenditure Forecast Model 76
Notes On Methodology 77
Risk/Reward Index Methodology 78
Index Overview 79
Table: Pharmaceutical Risk/Reward Index Indicators 79
Indicator Weightings 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.